|1.||Parrozzani, Raffaele: 1 article (02/2015)|
|2.||Bartolo, Ottavia: 1 article (02/2015)|
|3.||Lazzarini, Daniela: 1 article (02/2015)|
|4.||Fregona, Iva Angela: 1 article (02/2015)|
|5.||Leonardi, Andrea: 1 article (02/2015)|
|6.||Sturniolo, Giacomo Carlo: 1 article (02/2015)|
|7.||Midena, Edoardo: 1 article (02/2015)|
|8.||Berton, Marianna: 1 article (02/2015)|
|9.||Watanabe, Akihiro: 1 article (01/2014)|
|10.||Ishinokami, Saori: 1 article (01/2014)|
10/15/1996 - "This study was a randomized, double-blind, placebo-controlled, ascending-dose trial of sBNP administered as a single intravenous bolus in 27 heart failure patients. "
10/15/1996 - "Further clinical investigations to determine the use of sBNP in decompensated heart failure are clearly warranted."
10/15/1996 - "sBNP injected as a single intravenous bolus in heart failure patients improves hemodynamics in a dose-related fashion. "
|2.||Peripheral Nervous System Diseases (PNS Diseases)
02/01/2015 - "The CCM showed significant corneal changes in SBNP, with concomitant corneal epithelium changes in WD, demonstrating the presence of small fiber peripheral neuropathy in these patients. "
07/01/2013 - "In DM correlation of corneal sensitivity, SBNP density, and peripheral biothesiometry may have a potential role in estimating the severity of peripheral neuropathy. "
07/01/2013 - "To assess the effects of panretinal photocoagulation (PRP) for diabetic retinopathy (DR) on the human corneal subbasal nerve plexus (SBNP) and to investigate correlations between corneal subbasal nerve (SBN) density, corneal sensitivity, and diabetic peripheral neuropathy. "
01/01/1981 - "These findings suggest that estimation of BTP obtained from subarachnoid screw-type devices may not accurately record the pressure within cerebral tissue and the SBNP should not be administered to patients with known or suspected intracranial hypertension unless an intracranial (either BTP or subarachnoid) pressure is being monitored."
|4.||Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
|5.||Hepatolenticular Degeneration (Wilson's Disease)
|1.||Brain Natriuretic Peptide (Natrecor)